Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> AstraZeneca & Oxford University Suspend COVID-19 Vaccine Trial To Investigate Potential Severe Adverse Reaction 09/09/2020 Grace Ren AstraZeneca on Tuesday night suspended the Phase 3 trial of their experimental COVID-19 vaccine in order to investigate a a suspected severe adverse reaction in a volunteer reported in the United Kingdom. The trial suspension follows just on the heels of AstraZeneca’s chief executive officer’s pledge to seek regulatory approval for a COVID-19 vaccine only […] Continue reading -> Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Emergency Use Approval Is A “Temporary Solution,” Countries Should Wait For Large Clinical Trials To Finish To Roll Out A COVID-19 Vaccine En Masse 07/09/2020 Grace Ren Countries would be better off waiting until Phase 3 clinical trials, which test the safety and efficacy of an experimental vaccine in tens of thousands of people, are completed before rolling out the vaccine for wider use, World Health Organization Chief Scientist Soumya Swaminathan said on Monday. Although some countries, including China, Russia and the […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> The US Will Not Participate In WHO-Led Global COVID-19 Vaccine Initiative, Says White House Spokesperson 02/09/2020 Grace Ren A White House spokesperson on Tuesday said that the United States would not be joining the COVAX Facility, an initiative led by the World Health Organization and its partners to pool global demand for a COVID-19 vaccine, and ensure its equitable distribution. “The United States will continue to engage our international partners to ensure we […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> AstraZeneca & Oxford University Suspend COVID-19 Vaccine Trial To Investigate Potential Severe Adverse Reaction 09/09/2020 Grace Ren AstraZeneca on Tuesday night suspended the Phase 3 trial of their experimental COVID-19 vaccine in order to investigate a a suspected severe adverse reaction in a volunteer reported in the United Kingdom. The trial suspension follows just on the heels of AstraZeneca’s chief executive officer’s pledge to seek regulatory approval for a COVID-19 vaccine only […] Continue reading -> Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Emergency Use Approval Is A “Temporary Solution,” Countries Should Wait For Large Clinical Trials To Finish To Roll Out A COVID-19 Vaccine En Masse 07/09/2020 Grace Ren Countries would be better off waiting until Phase 3 clinical trials, which test the safety and efficacy of an experimental vaccine in tens of thousands of people, are completed before rolling out the vaccine for wider use, World Health Organization Chief Scientist Soumya Swaminathan said on Monday. Although some countries, including China, Russia and the […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> The US Will Not Participate In WHO-Led Global COVID-19 Vaccine Initiative, Says White House Spokesperson 02/09/2020 Grace Ren A White House spokesperson on Tuesday said that the United States would not be joining the COVAX Facility, an initiative led by the World Health Organization and its partners to pool global demand for a COVID-19 vaccine, and ensure its equitable distribution. “The United States will continue to engage our international partners to ensure we […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> AstraZeneca & Oxford University Suspend COVID-19 Vaccine Trial To Investigate Potential Severe Adverse Reaction 09/09/2020 Grace Ren AstraZeneca on Tuesday night suspended the Phase 3 trial of their experimental COVID-19 vaccine in order to investigate a a suspected severe adverse reaction in a volunteer reported in the United Kingdom. The trial suspension follows just on the heels of AstraZeneca’s chief executive officer’s pledge to seek regulatory approval for a COVID-19 vaccine only […] Continue reading -> Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Emergency Use Approval Is A “Temporary Solution,” Countries Should Wait For Large Clinical Trials To Finish To Roll Out A COVID-19 Vaccine En Masse 07/09/2020 Grace Ren Countries would be better off waiting until Phase 3 clinical trials, which test the safety and efficacy of an experimental vaccine in tens of thousands of people, are completed before rolling out the vaccine for wider use, World Health Organization Chief Scientist Soumya Swaminathan said on Monday. Although some countries, including China, Russia and the […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> The US Will Not Participate In WHO-Led Global COVID-19 Vaccine Initiative, Says White House Spokesperson 02/09/2020 Grace Ren A White House spokesperson on Tuesday said that the United States would not be joining the COVAX Facility, an initiative led by the World Health Organization and its partners to pool global demand for a COVID-19 vaccine, and ensure its equitable distribution. “The United States will continue to engage our international partners to ensure we […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
AstraZeneca & Oxford University Suspend COVID-19 Vaccine Trial To Investigate Potential Severe Adverse Reaction 09/09/2020 Grace Ren AstraZeneca on Tuesday night suspended the Phase 3 trial of their experimental COVID-19 vaccine in order to investigate a a suspected severe adverse reaction in a volunteer reported in the United Kingdom. The trial suspension follows just on the heels of AstraZeneca’s chief executive officer’s pledge to seek regulatory approval for a COVID-19 vaccine only […] Continue reading -> Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Emergency Use Approval Is A “Temporary Solution,” Countries Should Wait For Large Clinical Trials To Finish To Roll Out A COVID-19 Vaccine En Masse 07/09/2020 Grace Ren Countries would be better off waiting until Phase 3 clinical trials, which test the safety and efficacy of an experimental vaccine in tens of thousands of people, are completed before rolling out the vaccine for wider use, World Health Organization Chief Scientist Soumya Swaminathan said on Monday. Although some countries, including China, Russia and the […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> The US Will Not Participate In WHO-Led Global COVID-19 Vaccine Initiative, Says White House Spokesperson 02/09/2020 Grace Ren A White House spokesperson on Tuesday said that the United States would not be joining the COVAX Facility, an initiative led by the World Health Organization and its partners to pool global demand for a COVID-19 vaccine, and ensure its equitable distribution. “The United States will continue to engage our international partners to ensure we […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Emergency Use Approval Is A “Temporary Solution,” Countries Should Wait For Large Clinical Trials To Finish To Roll Out A COVID-19 Vaccine En Masse 07/09/2020 Grace Ren Countries would be better off waiting until Phase 3 clinical trials, which test the safety and efficacy of an experimental vaccine in tens of thousands of people, are completed before rolling out the vaccine for wider use, World Health Organization Chief Scientist Soumya Swaminathan said on Monday. Although some countries, including China, Russia and the […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> The US Will Not Participate In WHO-Led Global COVID-19 Vaccine Initiative, Says White House Spokesperson 02/09/2020 Grace Ren A White House spokesperson on Tuesday said that the United States would not be joining the COVAX Facility, an initiative led by the World Health Organization and its partners to pool global demand for a COVID-19 vaccine, and ensure its equitable distribution. “The United States will continue to engage our international partners to ensure we […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Emergency Use Approval Is A “Temporary Solution,” Countries Should Wait For Large Clinical Trials To Finish To Roll Out A COVID-19 Vaccine En Masse 07/09/2020 Grace Ren Countries would be better off waiting until Phase 3 clinical trials, which test the safety and efficacy of an experimental vaccine in tens of thousands of people, are completed before rolling out the vaccine for wider use, World Health Organization Chief Scientist Soumya Swaminathan said on Monday. Although some countries, including China, Russia and the […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> The US Will Not Participate In WHO-Led Global COVID-19 Vaccine Initiative, Says White House Spokesperson 02/09/2020 Grace Ren A White House spokesperson on Tuesday said that the United States would not be joining the COVAX Facility, an initiative led by the World Health Organization and its partners to pool global demand for a COVID-19 vaccine, and ensure its equitable distribution. “The United States will continue to engage our international partners to ensure we […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> The US Will Not Participate In WHO-Led Global COVID-19 Vaccine Initiative, Says White House Spokesperson 02/09/2020 Grace Ren A White House spokesperson on Tuesday said that the United States would not be joining the COVAX Facility, an initiative led by the World Health Organization and its partners to pool global demand for a COVID-19 vaccine, and ensure its equitable distribution. “The United States will continue to engage our international partners to ensure we […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> The US Will Not Participate In WHO-Led Global COVID-19 Vaccine Initiative, Says White House Spokesperson 02/09/2020 Grace Ren A White House spokesperson on Tuesday said that the United States would not be joining the COVAX Facility, an initiative led by the World Health Organization and its partners to pool global demand for a COVID-19 vaccine, and ensure its equitable distribution. “The United States will continue to engage our international partners to ensure we […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The US Will Not Participate In WHO-Led Global COVID-19 Vaccine Initiative, Says White House Spokesperson 02/09/2020 Grace Ren A White House spokesperson on Tuesday said that the United States would not be joining the COVAX Facility, an initiative led by the World Health Organization and its partners to pool global demand for a COVID-19 vaccine, and ensure its equitable distribution. “The United States will continue to engage our international partners to ensure we […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older posts